CTVA Corteva, Inc.
Agricultural Production-Crops · NYSE · SEC CIK 1755672 · Fiscal year ends 12/31
Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters
Growth
TTM revenue YoY1.0%
TTM net income YoY-52.7%
TTM EPS YoY-51.3%
Revenue 3-yr CAGR0.6%
Net income 3-yr CAGR-6.6%
Margins
Gross margin49.7%
Operating margin—
Net margin4.3%
FCF margin-0.8%
EBITDA margin—
Returns
ROE3.1%
ROA1.8%
ROIC (approx.)—
Asset turnover0.41x
Leverage & solvency
Liabilities / assets42.5%
Debt / equity0.30x
Current ratio1.56x
Interest coverage—
Cash quality & payout
Operating cash flow / net income0.56x
Accruals ratio0.8%
Payout ratio63.5%
Capex / revenue3.3%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | FY20252025-12-31 | FY20242024-12-31 |
|---|---|---|
| Income statement | ||
| Revenue | $17.40B | $16.91B |
| Cost of revenue | $9.17B | $9.53B |
| Gross profit | $8.23B | $7.38B |
| R&D expense | $1.47B | $1.40B |
| SG&A expense | $3.49B | $3.20B |
| Interest expense | $180.00M | $233.00M |
| Pretax income | $1.69B | $1.27B |
| Income tax | $484.00M | $412.00M |
| Net income | $1.09B | $907.00M |
| EPS (basic) | 1.60 | 1.31 |
| EPS (diluted) | 1.60 | 1.30 |
| Dividends declared per share | 0.70 | 0.66 |
| Weighted avg. shares (diluted) | 681.40M | 696.00M |
| Balance sheet | ||
| Cash & equivalents | $4.52B | $3.11B |
| Short-term investments | $9.00M | $63.00M |
| Receivables | $4.88B | $4.45B |
| Inventory | $5.67B | $5.43B |
| Current assets | $17.34B | $15.10B |
| PP&E, net | $4.22B | $4.10B |
| Goodwill | $10.46B | $10.41B |
| Intangibles | $8.30B | $8.88B |
| Total assets | $42.84B | $40.83B |
| Current liabilities | $12.12B | $10.39B |
| Short-term debt | $894.00M | $750.00M |
| Long-term debt | $1.69B | $1.95B |
| Total debt | $2.58B | $2.70B |
| Total liabilities | $18.46B | $16.80B |
| Shareholders' equity | $24.14B | $23.79B |
| Net debt | -$1.94B | -$403.00M |
| Shares outstanding | 672.16M | 685.60M |
| Cash flow statement | ||
| Operating cash flow | $3.41B | $2.15B |
| Capital expenditure | $591.00M | $597.00M |
| Free cash flow | $2.81B | $1.55B |
| Investing cash flow | -$543.00M | -$589.00M |
| Financing cash flow | -$1.64B | -$1.20B |
| Depreciation & amortization | $1.20B | $1.23B |
| Dividends paid | $475.00M | $458.00M |
| Share buybacks | $1.07B | $1.01B |
Free plan shows the latest 2 periods; Pro shows all 8 🔒
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.